Can Rectal Cancer Patients with Complete Response to Neoadjuvant Chemoradiotherapy Avoid Surgery?

Area of Science:

• Oncology
• Surgical Oncology
• Radiotherapy

Background:

• Rectal cancer is a prevalent malignancy globally.
• Neoadjuvant chemoradiotherapy (nCRT) is standard for locally advanced rectal cancer.
• The

Purpose of the Study:

• To evaluate the feasibility of the

Main Methods:

• Retrospective review of 41 patients undergoing neoadjuvant therapy for rectal cancer.
• MRI restaging was performed, with results compared to surgical excision or 3-month follow-up.
• Minimum 2-year follow-up for efficacy assessment of the

Main Results:

• The

Conclusions:

• The